HilleVax Statistics
Total Valuation
HilleVax has a market cap or net worth of $87.06 million. The enterprise value is -$78.00 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, before market open.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
HilleVax has 48.23 million shares outstanding. The number of shares has increased by 27.71% in one year.
Current Share Class | 48.23M |
Shares Outstanding | 48.23M |
Shares Change (YoY) | +27.71% |
Shares Change (QoQ) | +0.41% |
Owned by Insiders (%) | 5.27% |
Owned by Institutions (%) | 55.50% |
Float | 28.35M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.47 |
P/TBV Ratio | 0.47 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.25, with a Debt / Equity ratio of 0.14.
Current Ratio | 14.25 |
Quick Ratio | 13.68 |
Debt / Equity | 0.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -33.60 |
Financial Efficiency
Return on equity (ROE) is -62.24% and return on invested capital (ROIC) is -30.39%.
Return on Equity (ROE) | -62.24% |
Return on Assets (ROA) | -28.90% |
Return on Capital (ROIC) | -30.39% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.67M |
Employee Count | 90 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.82% in the last 52 weeks. The beta is 0.77, so HilleVax's price volatility has been lower than the market average.
Beta (5Y) | 0.77 |
52-Week Price Change | -86.82% |
50-Day Moving Average | 1.83 |
200-Day Moving Average | 8.50 |
Relative Strength Index (RSI) | 41.12 |
Average Volume (20 Days) | 133,289 |
Short Selling Information
The latest short interest is 1.18 million, so 2.44% of the outstanding shares have been sold short.
Short Interest | 1.18M |
Short Previous Month | 1.26M |
Short % of Shares Out | 2.44% |
Short % of Float | 4.16% |
Short Ratio (days to cover) | 8.81 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -135.87M |
Pretax Income | -156.27M |
Net Income | -150.28M |
EBITDA | -134.04M |
EBIT | -135.87M |
Earnings Per Share (EPS) | -$3.09 |
Full Income Statement Balance Sheet
The company has $189.31 million in cash and $24.97 million in debt, giving a net cash position of $164.34 million or $3.41 per share.
Cash & Cash Equivalents | 189.31M |
Total Debt | 24.97M |
Net Cash | 164.34M |
Net Cash Per Share | $3.41 |
Equity (Book Value) | 184.27M |
Book Value Per Share | 3.82 |
Working Capital | 183.33M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$112.21 million and capital expenditures -$1.15 million, giving a free cash flow of -$113.36 million.
Operating Cash Flow | -112.21M |
Capital Expenditures | -1.15M |
Free Cash Flow | -113.36M |
FCF Per Share | -$2.35 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |